{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:53:20Z","timestamp":1774630400728,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07902-y","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:05:47Z","timestamp":1772165147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesenchymal stromal cell therapy for post-COVID-19 syndrome: associated impact and mechanism"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuefei","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junli","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengyun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaidi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunbo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-6685","authenticated-orcid":false,"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"7902_CR1","unstructured":"Coronavirus disease (COVID-19) situation reports [Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"7902_CR2","doi-asserted-by":"publisher","first-page":"108891","DOI":"10.1016\/j.pharmthera.2025.108891","volume":"272","author":"ECA Vreeman","year":"2025","unstructured":"Vreeman ECA, Pillay J, Burgess JK. Post-COVID pulmonary sequelae: mechanisms and potential targets to reduce persistent fibrosis. Pharmacol Ther. 2025;272:108891.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"7902_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41582-023-00917-9","volume":"20","author":"DS Goldstein","year":"2024","unstructured":"Goldstein DS. Post-COVID dysautonomias: what we know and (mainly) what we don\u2019t know. Nat Rev Neurol. 2024;20(2):99\u2013113.","journal-title":"Nat Rev Neurol"},{"key":"7902_CR4","doi-asserted-by":"crossref","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. The Lancet Infect Dis. 2022;22(4):e102\u20137.","DOI":"10.1016\/S1473-3099(21)00703-9"},{"issue":"8","key":"7902_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S1473-3099(24)00171-3","volume":"24","author":"W Zuo","year":"2024","unstructured":"Zuo W, He D, Liang C, Du S, Hua Z, Nie Q, et al. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. The Lancet Infect Dis. 2024;24(8):845\u201355.","journal-title":"The Lancet Infect Dis"},{"key":"7902_CR6","doi-asserted-by":"publisher","first-page":"102107","DOI":"10.1016\/j.eclinm.2023.102107","volume":"62","author":"E Gentilotti","year":"2023","unstructured":"Gentilotti E, Gorska A, Tami A, Gusinow R, Mirandola M, Rodriguez Bano J, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107.","journal-title":"EClinicalMedicine"},{"issue":"6685","key":"7902_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1126\/science.adl0867","volume":"383","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly Z, Topol E. Solving the puzzle of Long Covid. Science. 2024;383(6685):830\u201332.","journal-title":"Science"},{"key":"7902_CR8","doi-asserted-by":"crossref","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome Coronavirus 2 Spike is associated with post-acute Coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76(3):e487\u201390.","DOI":"10.1093\/cid\/ciac722"},{"key":"7902_CR9","doi-asserted-by":"publisher","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","volume":"12","author":"AD Proal","year":"2021","unstructured":"Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169.","journal-title":"Front Microbiol"},{"issue":"4","key":"7902_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/ID9.0000000000000163","volume":"5","author":"S Liu","year":"2025","unstructured":"Liu S, Guo Y, Wang F-S. Viral persistence in long COVID: research advances and treatment strategies. Infect Dis Immun. 2025;5(4):272\u201388.","journal-title":"Infect Dis Immun"},{"issue":"3","key":"7902_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"7902_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2021.12.040","volume":"185","author":"P Georg","year":"2022","unstructured":"Georg P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022;185(3):493\u2013512 e25.","journal-title":"Cell"},{"key":"7902_CR13","doi-asserted-by":"crossref","unstructured":"Cervia-Hasler C, Br\u00fcningk SC, Hoch T, Fan B, Muzio G, Thompson RC, et al. Persistent complement dysregulation with signs of thromboinflammation in active long Covid. Science. 2024;383(6680):eadg7942.","DOI":"10.1126\/science.adg7942"},{"key":"7902_CR14","doi-asserted-by":"publisher","first-page":"745758","DOI":"10.3389\/fcvm.2021.745758","volume":"8","author":"S Charfeddine","year":"2021","unstructured":"Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front. Cardiovasc. Med. 2021;8:745758.","journal-title":"Front. Cardiovasc. Med"},{"issue":"1","key":"7902_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-022-01579-5","volume":"21","author":"E Pretorius","year":"2022","unstructured":"Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/Post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21(1):148.","journal-title":"Cardiovasc Diabetol"},{"issue":"6578","key":"7902_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.abm2052","volume":"375","author":"S Spudich","year":"2022","unstructured":"Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267\u201369.","journal-title":"Science"},{"issue":"20","key":"7902_CR17","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187(20):5500\u201329.","journal-title":"Cell"},{"key":"7902_CR18","doi-asserted-by":"publisher","first-page":"104293","DOI":"10.1016\/j.ebiom.2022.104293","volume":"85","author":"G Captur","year":"2022","unstructured":"Captur G, Moon JC, Topriceanu CC, Joy G, Swadling L, Hallqvist J, et al. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. EBioMedicine. 2022;85:104293.","journal-title":"EBioMedicine"},{"key":"7902_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-052422-020316","volume":"75","author":"HS Andrews","year":"2024","unstructured":"Andrews HS, Herman JD, Gandhi RT. Treatments for COVID-19. Annu. Rev. Med. 2024;75:145\u201357.","journal-title":"Annu. Rev. Med"},{"issue":"1","key":"7902_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","volume":"11","author":"L Shu","year":"2020","unstructured":"Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, et al. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2020;11(1):361.","journal-title":"STEM Cell Res Ther"},{"issue":"1","key":"7902_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41392-021-00754-6","volume":"6","author":"L Shi","year":"2021","unstructured":"Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, et al. Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther. 2021;6(1):339.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"7902_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41392-021-00488-5","volume":"6","author":"L Shi","year":"2021","unstructured":"Shi L, Huang H, Lu X, Yan X, Jiang X, Xu R, et al. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021;6(1):58.","journal-title":"Signal Transduct Target Ther"},{"key":"7902_CR23","doi-asserted-by":"publisher","first-page":"100454","DOI":"10.1016\/j.eclinm.2020.100454","volume":"25","author":"F Sanchez-Guijo","year":"2020","unstructured":"Sanchez-Guijo F, Garcia-Arranz M, Lopez-Parra M, Monedero P, Mata-Martinez C, Santos A, et al. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine. 2020;25:100454.","journal-title":"EClinicalMedicine"},{"key":"7902_CR24","doi-asserted-by":"crossref","unstructured":"Xu X, Jiang W, Chen L, Xu Z, Zhang Q, Zhu M, et al. Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: an exploratory clinical trial. Clin Transl Med. 2021;11(2):e297.","DOI":"10.1002\/ctm2.297"},{"key":"7902_CR25","doi-asserted-by":"publisher","first-page":"963689721102494","DOI":"10.1177\/09636897211024942","volume":"30","author":"G Adas","year":"2021","unstructured":"Adas G, Cukurova Z, Yasar KK, Yilmaz R, Isiksacan N, Kasapoglu P, et al. The Systematic Effect of mesenchymal stem cell therapy in critical COVID-19 patients: a prospective double controlled trial. Cell Transpl. 2021;30:9636897211024942.","journal-title":"Cell Transpl"},{"key":"7902_CR26","doi-asserted-by":"publisher","first-page":"103789","DOI":"10.1016\/j.ebiom.2021.103789","volume":"75","author":"L Shi","year":"2022","unstructured":"Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, et al. Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2022;75:103789.","journal-title":"EBioMedicine"},{"key":"7902_CR27","doi-asserted-by":"publisher","first-page":"104600","DOI":"10.1016\/j.ebiom.2023.104600","volume":"92","author":"TT Li","year":"2023","unstructured":"Li TT, Zhang B, Fang H, Shi M, Yao WQ, Li Y, et al. Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2023;92:104600.","journal-title":"EBioMedicine"},{"issue":"1","key":"7902_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13287-025-04148-1","volume":"16","author":"MQ Yuan","year":"2025","unstructured":"Yuan MQ, Song L, Wang ZR, Zhang ZY, Shi M, He J, et al. Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial. Stem Cell Res Ther. 2025;16(1):94.","journal-title":"STEM Cell Res Ther"},{"issue":"7","key":"7902_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/stcltm\/szac032","volume":"11","author":"W Qu","year":"2022","unstructured":"Qu W, Wang Z, Engelberg-Cook E, Yan D, Siddik AB, Bu G, et al. Efficacy and safety of MSC cell therapies for hospitalized patients with COVID-19: a Systematic review and meta-analysis. Stem Cells Transl Med. 2022;11(7):688\u2013703.","journal-title":"STEM Cells Transl Med"},{"issue":"1","key":"7902_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11948-000-0025-z","volume":"6","author":"D Switula","year":"2000","unstructured":"Switula D. Principles of good clinical practice (GCP) in clinical research. Sci Eng Ethics. 2000;6(1):71\u201377.","journal-title":"Sci Eng Ethics"},{"issue":"11","key":"7902_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/CM9.0000000000000866","volume":"133","author":"JY Zhao","year":"2020","unstructured":"Zhao JY, Yan JY, Qu JM. Interpretations of \u201cDiagnosis and treatment protocol for novel Coronavirus pneumonia (trial version 7)\u201d. Chin Med J (Engl). 2020;133(11):1347\u201349.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"7902_CR32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1148\/radiol.2020200370","volume":"295","author":"F Pan","year":"2020","unstructured":"Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from Coronavirus disease 2019 (COVID-19). Radiology. 2020;295(3):715\u201321.","journal-title":"Radiology"},{"issue":"12","key":"7902_CR33","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1007\/s00330-020-07033-y","volume":"30","author":"M Francone","year":"2020","unstructured":"Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30(12):6808\u201317.","journal-title":"Eur Radiol"},{"issue":"10270","key":"7902_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220\u201332.","journal-title":"Lancet"},{"issue":"1","key":"7902_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"L ATSCoPsfcpf","year":"2002","unstructured":"Laboratories ATSCoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111\u201317.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5 Pt 1","key":"7902_CR36","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","volume":"158","author":"PL Enright","year":"1998","unstructured":"Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1384\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"7902_CR37","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2213-2600(21)00174-0","volume":"9","author":"X Wu","year":"2021","unstructured":"Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747\u201354.","journal-title":"Lancet Respir Med"},{"key":"7902_CR38","doi-asserted-by":"crossref","unstructured":"Rajala K, Lehto JT, Sutinen E, Kautiainen H, Myllarniemi M, Saarto T. mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis. Erj Open Res. 2017;3(4).","DOI":"10.1183\/23120541.00084-2017"},{"issue":"7","key":"7902_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581\u201386.","journal-title":"Thorax"},{"key":"7902_CR40","doi-asserted-by":"crossref","unstructured":"Ware JE Jr. SF-36 health survey update. Spine (phila Pa 1976). 2000. 25(24):3130\u201339.","DOI":"10.1097\/00007632-200012150-00008"},{"issue":"2","key":"7902_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","volume":"37","author":"T Chalder","year":"1993","unstructured":"Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147\u201353.","journal-title":"J Psychosom Res"},{"issue":"3","key":"7902_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315\u201325.","journal-title":"J Psychosom Res"},{"key":"7902_CR43","doi-asserted-by":"publisher","first-page":"1158951","DOI":"10.3389\/fimmu.2023.1158951","volume":"14","author":"R Gong","year":"2023","unstructured":"Gong R, Luo H, Long G, Xu J, Huang C, Zhou X, et al. Integrative proteomic profiling of lung tissues and blood in acute respiratory distress syndrome. Front Immunol. 2023;14:1158951.","journal-title":"Front Immunol"},{"key":"7902_CR44","doi-asserted-by":"publisher","first-page":"101651","DOI":"10.1016\/j.eclinm.2022.101651","volume":"53","author":"TJ Hartung","year":"2022","unstructured":"Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. EClinicalMedicine. 2022;53:101651.","journal-title":"EClinicalMedicine"},{"key":"7902_CR45","doi-asserted-by":"crossref","unstructured":"Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374: n 1648).","DOI":"10.1136\/bmj.n1648"},{"issue":"1","key":"7902_CR46","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acsnano.0c08947","volume":"15","author":"M Zhao","year":"2021","unstructured":"Zhao M, Liu S, Wang C, Wang Y, Wan M, Liu F, et al. Mesenchymal stem cell-derived extracellular vesicles attenuate mitochondrial damage and inflammation by stabilizing mitochondrial DNA. ACS Nano. 2021;15(1):1519\u201338.","journal-title":"ACS Nano"},{"issue":"1","key":"7902_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13034-025-00910-8","volume":"19","author":"E Frentzen","year":"2025","unstructured":"Frentzen E, Fegert JM, Martin A, Witt A. Child and adolescent mental health during the Covid-19 pandemic: an overview of key findings from a thematic series. Child Adolesc Psychiatry Ment Health. 2025;19(1):57.","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"4","key":"7902_CR48","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/dx-2021-0046","volume":"8","author":"PJ Chen","year":"2021","unstructured":"Chen PJ, Pusica Y, Sohaei D, Prassas I, Diamandis EP. An overview of mental health during the COVID-19 pandemic. Diagnosis (Berl). 2021;8(4):403\u201312.","journal-title":"Diagnosis (Berl)"},{"key":"7902_CR49","doi-asserted-by":"publisher","first-page":"103766","DOI":"10.1016\/j.redox.2025.103766","volume":"85","author":"TH Chen","year":"2025","unstructured":"Chen TH, Jeng TH, Lee MY, Wang HC, Tsai KF, Chou CK. Viral mitochondriopathy in COVID-19. Redox Biol. 2025;85:103766.","journal-title":"Redox Biol"},{"issue":"1","key":"7902_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther. 2016;7(1):125.","journal-title":"STEM Cell Res Ther"},{"issue":"5","key":"7902_CR51","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1007\/s11357-024-01165-5","volume":"46","author":"T Molnar","year":"2024","unstructured":"Molnar T, Lehoczki A, Fekete M, Varnai R, Zavori L, Erdo-Bonyar S, et al. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience. 2024;46(5):5267\u201386.","journal-title":"Geroscience"},{"issue":"8","key":"7902_CR52","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/stcltm\/szae038","volume":"13","author":"J Song","year":"2024","unstructured":"Song J, Wang L, Wang L, Guo X, He Q, Cui C, et al. Mesenchymal stromal cells ameliorate mitochondrial dysfunction in \u03b1 cells and hyperglucagonemia in type 2 diabetes via SIRT1\/FoxO3a signaling. Stem Cells Transl Med. 2024;13(8):776\u201390.","journal-title":"STEM Cells Transl Med"},{"issue":"2","key":"7902_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"K Yin","year":"2024","unstructured":"Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25(2):218\u201325.","journal-title":"Nat Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07902-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07902-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07902-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:01:58Z","timestamp":1774627318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07902-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7902"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07902-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Fifth Medical Center of the Chinese PLA General Hospital (Approval No. 2020\u2013023-D). All participants provided written informed consent prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WQY was an employee of Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd. YZ and TYD are current employees of the same company. All the other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}